To say 2020 has been a year unlike any other so far would be an understatement. COVID-19 has caused the tragic loss of more than 200,000 lives and left permanent scars on many of those fortunate enough to recover from significant disease.

High-performance computing is a powerful weapon in the fight to find treatments and cures for all kinds of diseases.

Essential Questions To Ask When Evaluating Your...

Biotech and pharmaceutical organizations are at the forefront of some of the world’s biggest problems. From developing pest-resistant crops, creating new biofuels, and treating deadly diseases, the march of scientific advancement enables the march of social and civic progress.

AI training is  driving HPC advances in drug...

The climate in which R&D teams are operating today is competitive, to say the least. 

The breakneck pace at which innovation must move in its earliest of stages creates a battleground within the research landscape, one where data is the best weapon against the invisible enemies science aims to destroy, and technology provides the differentiating high-ground from which the fight can be won. 

The sprint toward early discovery is one of the most important legs in the long, expensive, and compliance-driven relay race to bring new drugs or treatments to market. Not only does being first to market with medical innovation provide companies with the opportunity to patent and sell a new treatment as the sole distributor, the reputational value associated with doing so can also be almost immeasurable.